Xie Mengzhang, Gong Taojun, Wang Yitian, Li Zhuangzhuang, Lu Minxun, Luo Yi, Min Li, Tu Chongqi, Zhang Xingdong, Zeng Qin, Zhou Yong
Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China.
National Engineering Biomaterials, Sichuan University Research Center for Chengdu, Chengdu 610064, China.
Int J Mol Sci. 2024 Apr 9;25(8):4139. doi: 10.3390/ijms25084139.
Bone tumors, particularly osteosarcoma, are prevalent among children and adolescents. This ailment has emerged as the second most frequent cause of cancer-related mortality in adolescents. Conventional treatment methods comprise extensive surgical resection, radiotherapy, and chemotherapy. Consequently, the management of bone tumors and bone regeneration poses significant clinical challenges. Photothermal tumor therapy has attracted considerable attention owing to its minimal invasiveness and high selectivity. However, key challenges have limited its widespread clinical use. Enhancing the tumor specificity of photosensitizers through targeting or localized activation holds potential for better outcomes with fewer adverse effects. Combinations with chemotherapies or immunotherapies also present avenues for improvement. In this review, we provide an overview of the most recent strategies aimed at overcoming the limitations of photothermal therapy (PTT), along with current research directions in the context of bone tumors, including (1) target strategies, (2) photothermal therapy combined with multiple therapies (immunotherapies, chemotherapies, and chemodynamic therapies, magnetic, and photodynamic therapies), and (3) bifunctional scaffolds for photothermal therapy and bone regeneration. We delve into the pros and cons of these combination methods and explore current research focal points. Lastly, we address the challenges and prospects of photothermal combination therapy.
骨肿瘤,尤其是骨肉瘤,在儿童和青少年中很常见。这种疾病已成为青少年癌症相关死亡的第二大常见原因。传统的治疗方法包括广泛的手术切除、放疗和化疗。因此,骨肿瘤的治疗和骨再生带来了重大的临床挑战。光热肿瘤治疗因其微创性和高选择性而备受关注。然而,关键挑战限制了其广泛的临床应用。通过靶向或局部激活提高光敏剂的肿瘤特异性有可能在减少不良反应的情况下取得更好的效果。与化疗或免疫疗法的联合也提供了改进的途径。在这篇综述中,我们概述了旨在克服光热疗法(PTT)局限性的最新策略,以及在骨肿瘤背景下的当前研究方向,包括(1)靶向策略,(2)光热疗法与多种疗法(免疫疗法、化疗、化学动力学疗法、磁疗法和光动力疗法)联合,以及(3)用于光热疗法和骨再生的双功能支架。我们深入探讨了这些联合方法的优缺点,并探索了当前的研究重点。最后,我们阐述了光热联合疗法的挑战和前景。
Int J Mol Sci. 2024-4-9
Int J Pharm. 2024-11-15
Nat Rev Clin Oncol. 2020-11
Int J Mol Sci. 2021-10-21
J Nanobiotechnology. 2023-9-27
Int J Biol Sci. 2021
Mater Today Bio. 2025-7-3
Front Bioeng Biotechnol. 2025-5-27
Front Chem. 2025-5-26
Nanomedicine (Lond). 2025-5
Mater Today Bio. 2025-2-5
Molecules. 2024-12-11
ACS Appl Bio Mater. 2024-3-18
Front Bioeng Biotechnol. 2023-10-2